EMA
safety_alert
· 2021-07-09
EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
Summary
EMA advises against using the COVID-19 Vaccine Janssen in individuals with a history of capillary leak syndrome due to risk of serious adverse events.
Upgrade for the full analysis, importance score, and drug timeline.